Femme et Homme
- | Pays :
- France
- United States
- Belgium
- ...
- | Organes : -
- | Spécialités : -
Extrait
The objectives of this study are to assess the safety, tolerability, pharmacokinetics, pharmacodynamics and clinical outcome of patients who have severe pneumonia caused by Staphylococcus aureus (S. aureus) after a single intravenous administration of KBSA301 in addition of standard of care antibiotic treatment.
Critère d'inclusion
- Pneumonia due to staphylococcus aureus